Background
==========

Confocal laser endomicroscopy (CLE) is a widely used technique in gastroenterology. It is an endoscopic tool that allows *in vivo* (during ongoing endoscopy) or *in vitro* histology at subcellular resolution by using (fluorescence) contrast agents \[[@b1-medscimonit-24-4198]\]. The most commonly used contrast agents are acriflavine hydrochloride (topical use only) and fluorescein sodium \[[@b2-medscimonit-24-4198]\].

In gastroenterology, CLE has been used for detection, classification and/or monitoring of colon polyps/cancer \[[@b3-medscimonit-24-4198]\], Barrett's esophagus \[[@b4-medscimonit-24-4198]\], ulcerative colitis, Crohn's disease \[[@b5-medscimonit-24-4198]\], and many other conditions. In contrast, in pulmonology this method lacks a well-recognized scope. However, Thiberville et al. were able to display parts of normal proximal and distal bronchial system during a flexible bronchoscopy with CLE \[[@b6-medscimonit-24-4198]\]. Furthermore, CLE has been effectively used for diagnosis and monitoring of pulmonary alveolar proteinosis \[[@b7-medscimonit-24-4198],[@b8-medscimonit-24-4198]\], as well as for diagnosis of pneumocystis jirovecii and amiodaron related pneumonia \[[@b9-medscimonit-24-4198],[@b10-medscimonit-24-4198]\]. Likewise, characteristic changes in cases of acute lung allograft rejection have been identified \[[@b11-medscimonit-24-4198]\]. Other encouraging studies have been performed showing the differentiation of normal bronchial mucosa from cancer tissue *in vivo* and *ex vivo* using CLE \[[@b12-medscimonit-24-4198],[@b13-medscimonit-24-4198]\]. Even solitary lung nodules have been imaged applying CLE \[[@b14-medscimonit-24-4198],[@b15-medscimonit-24-4198]\]. Nevertheless, CLE is still not implemented in routine clinical practice and the application currently is thought to be experimental.

In quest of an appropriate area of application, our study group analyzed CLE-based pleural effusions. CLE permitted simple and rapid detection of malignant cells in previously stained pleural effusions (data not shown, publication in progress). Furthermore, this study was initiated to determine the value of CLE in characterization of BALF components. In previous studies, BALF underwent already a CLE-based analysis but only in a native setting. When consistently used in present or former smokers, alveolar macrophages as the main BALF component have been shown due to tobacco tar specific fluorescence \[[@b16-medscimonit-24-4198]\]. This effect holds even after smoking cessation for a long time (for a minimum of 6--15 months after smoking cessation with great individual variation) \[[@b17-medscimonit-24-4198]\]. Sometimes the fluorescence imparted upon alveolar macrophages from cigarette smoking can take years to fully diminish \[[@b16-medscimonit-24-4198],[@b17-medscimonit-24-4198]\] and there is *in vitro* evidence that air pollution has a similar effect on macrophage fluorescence \[[@b18-medscimonit-24-4198]\]. By contrast, alveolar macrophages were not visible in non-smoking healthy subjects. The same observation was made by performing CLE during bronchoscopy and pushing the probe into the subdivisions of the bronchial tree \[[@b10-medscimonit-24-4198],[@b19-medscimonit-24-4198]\]. Interestingly, in some diseases, macrophages and presumably even leucocytes could be detected using CLE natively \[[@b10-medscimonit-24-4198]\]. For comparable results, and in expectation of better contrast and a more detailed view, we chose to stain the BAL fluid with the often-used dye acriflavine. Previously, we conducted a pre-pilot study with a small sample size (n=10; 8 smokers, 2 non-smoker) comparing stained to non-stained fluids. With acriflavine, we got a much better contrast. Alveolar macrophages were easily detectable regardless of smoking or non-smoking probands, as well as leucocytes. In unstained samples, sometimes only a non-distinguishable cell mass could be shown by CLE. Therefore, only stained samples were analyzed in this study. To our knowledge, this is the first report on applying CLE to analyze stained BALF.

Bronchoscopic evaluation with BAL has been an approved technique for a long time and provides important diagnostic information in patients with pulmonary diseases (immunodeficient or not) \[[@b20-medscimonit-24-4198]\]. As a safe method, it is routinely performed when clinically indicated. Such indications might be: microbial detection, differentiation of interstitial pulmonary diseases, or proof of malignant cells. Especially in patients with suspected interstitial lung diseases, a clear and quantitative differentiation of all BALF components (such as alveolar macrophages, lymphocytes, neutrophilic or eosinophilic granulocytes) is pivotal for diagnostic and therapeutic decisions. The aim of this study was to evaluate whether CLE-based analyses can provide this important information "real-time".

Material and Methods
====================

This prospective study was approved by the local ethical committee (*<http://www.ethikkomitee.med.uni-erlangen.de>*) and was conducted according to the Declaration of Helsinki. Patients who underwent bronchoscopy with bronchoalveolar lavage between August 2012 and September 2012 for evaluation of pulmonary infiltrates were recruited for this study. The bronchoscopic procedure was explained to all participants in detail and participants gave their written informed consent. Twenty-one patients suffering from diverse underlying diseases were included in this study ([Table 1](#t1-medscimonit-24-4198){ref-type="table"}). All participants underwent a flexible white light video-chip bronchoscopy (Olympus BF 1T180 or BF Q180, Olympus, Tokyo, Japan). For sedoanalgesia, we used intravenous midazolam (5 mg to 8 mg) alone or in combination with pethidine (50 mg to 100 mg). For topical anesthesia we used lidocaine solution limited to 4.5 mg/kg body weight. For routine monitoring, ECG, pulse oximetry, and intermitted non-invasive measurement of blood pressure were reported. Each patient received a minimum of 2 L O~2~/minute via nasal probe.

First the bronchial system was carefully inspected. Anomalies and signs of malignancy were documented in detail and biopsied after realization of BAL.

BAL was performed with 100 mL lukewarm sodium chloride 0.9% solution at the radiological suspicious lung area. The recovery fluid (30--50 mL) was divided into 3 or 4 parts. One was sent to microbiology, one to cytology, one in a few cases to virology, and one was used for this study. Acriflavine (2.5 mg acriflavine dissolved in 1 mL sodium chloride 0.9%, Sigma Aldrich) was added to each study sample.

Acriflavine passes through cell membranes and displays a strong specificity for labeling acidic constituents providing a clear visualization of the nuclei and cytoplasm \[[@b21-medscimonit-24-4198]\]. After shaking the probe carefully (for a good staining result) they were centrifugated (4°C, 1500 rpm, 10 minutes). The cell pellet was than analyzed by CLE by an experienced investigator.

We used the commercial Cellvizio system (Mauna Kea Technologies, Paris, France). A confocal miniprobe S type (1.4-mm diameter; SN: DM-2023, Mauna Kea Technologies) was applied which displayed a penetration depth of 0--50 μm, a lateral resolution of 3.5 μm and a field of view of 600×500 μm.

The video sequences were assessed with the included software (Cellvizio viewer, version 1.4.1; Mauna Kea Technologies). We selected a grey scaled imaging with the lower and upper level thresholds of the reference lookup table from 0 to 8000 units. The video sequences were recorded for further adjustment.

Results
=======

Twenty-one patients with various infectious, malignant, autoimmune, and other diseases were included in this study ([Table 1](#t1-medscimonit-24-4198){ref-type="table"}). Confocal laser endomicroscopy was used as a new diagnostic approach for analyzing BALF. Acriflavine was applied as the contrast agent, predominantly staining cell nuclei and to a lesser extent cytoplasm.

By means of CLE, a good distinction of alveolar macrophages and leucocytes in BALF could be made ([Figure 1](#f1-medscimonit-24-4198){ref-type="fig"}). A subdivision of primary lymphocyte, eosinophilic or neutrophilic granulocyte predominance was not achievable. Because there were strong cell nuclei staining and a rather small cell-plasma relation, acriflavine resulted in an outshining of the entire cell. So important factors of distinction (nucleus structure: rounded versus more lobular or cytoplasm content) were not visible.

Discussion
==========

Currently, confocal laser endomicroscopy rates high in medicine with evident diagnostic added value. Temporary CLE is especially useful in gastroenterology \[[@b3-medscimonit-24-4198],[@b5-medscimonit-24-4198],[@b22-medscimonit-24-4198]--[@b31-medscimonit-24-4198]\]. In addition, CLE has a possible application in the field of urology \[[@b32-medscimonit-24-4198],[@b33-medscimonit-24-4198]\], gynecology \[[@b34-medscimonit-24-4198]\], neurology \[[@b35-medscimonit-24-4198],[@b36-medscimonit-24-4198]\], and ENT medicine \[[@b37-medscimonit-24-4198],[@b38-medscimonit-24-4198]\]. Therefore, it is understandable that also in pulmonology several studies on CLE have been initiated. The main point of interest is whether CLE is suitable for pulmonological tissue. Studies have shown possible applications, that are the distinction between normal bronchial mucosa \[[@b6-medscimonit-24-4198],[@b39-medscimonit-24-4198]\] and tumorous infiltrated mucosa in *in vivo* and*ex vivo* settings \[[@b12-medscimonit-24-4198],[@b13-medscimonit-24-4198]\]. Moreover, pathologically altered tissue within the context of allograft rejection \[[@b11-medscimonit-24-4198]\], pulmonary alveolar microlithiasis \[[@b40-medscimonit-24-4198]\], pneumocystis jirovecii pneumonia \[[@b9-medscimonit-24-4198]\], and amiodarone-related pneumonia \[[@b10-medscimonit-24-4198]\] could be demonstrated applying CLE. In the past, even solitary lung nodules were classified by *in vivo* imaging using CLE \[[@b14-medscimonit-24-4198],[@b15-medscimonit-24-4198]\].

In this study, we focused on the identification of BALF cell components using CLE. This has been done before, but to our knowledge, our study is the first approach using acriflavine-stained BALF CLE-based analysis.

According to other *in vivo* studies \[[@b7-medscimonit-24-4198],[@b19-medscimonit-24-4198],[@b39-medscimonit-24-4198]\], we were able to illustrate alveolar macrophages in BAL fluid. However, these previous findings were restricted to smokers in a native setting due to tobacco tar specific fluorescence \[[@b16-medscimonit-24-4198]\] (and also to special inflammatory settings such as amiodaron related pneumonia \[[@b10-medscimonit-24-4198]\] or pulmonary alveolar proteinosis \[[@b7-medscimonit-24-4198]\]). However, we were able to show alveolar macrophages equally in non-smoking people. A distinction of leucocytes is based on cell size and cell nucleus; however, morphology is also used to easily identify cells (macrophage: 30--50 μm versus neutrophilic granulocyte 12--15 μm versus lymphocyte with varying size 4--20 μm). In an inflammatory setting such as amiodaron-related pneumonia, Salaün et al. reported CLE-based detection of 2 populations of fluorescent cells in the airways of non-smoker without using a special dye. One fraction was considered to represent alveolar macrophages; the other was presumably activated lymphocytes and/or neutrophils \[[@b10-medscimonit-24-4198]\]. Consistent with these findings, Yserbyt et al. revealed that auto-fluorescent cells were highly present in patients with acute lung allograft rejection \[[@b11-medscimonit-24-4198]\]. Thus, there might be special circumstances, such as inflammatory cell infiltration and cell activation as a consequence of various diseases, that can lead to an auto-fluorescence of macrophages and leucocytes even in nonsmoking patients \[[@b16-medscimonit-24-4198]\]. As mentioned before, smoking status has an important influence on macrophage auto-fluorescence. It increases with smoking duration and intensity as well as the number of macrophages; and even after smoking cessation this last for a long time. To avoid these influencing factors and to be able to analyze all samples regardless of disease or smoking status in a comparable way, requires tested staining methods. In our case, we used acriflavine, known to stain cytoplasm and nuclei. Additionally, this can lead to better contrasted pictures. However, a further clear differentiation of leucocytes and granulocytes (eosinophilic/neutrophilic) and lymphocytes was not part of our study. Since both leucocyte subgroups could present a similar cell size (dependent on the maturation/activation level of the lymphocytes), this method does not provide a reliable distinctive feature. The precise presentability of cell nucleus structure (rounded versus more lobular), cytoplasm content (eosinophilic granules), and nucleus-plasma relation, would be pivotal in this domain. This distinction could not be achieved by the results within the context of our pilot study. The obviously smaller cells in comparison to the alveolar macrophages showed a strong nuclear staining result by means of vital staining with acriflavine. Because of the rather small nucleus-plasma relation, this resulted in an outshining of the entire cell. Therefore, the distinguishing characteristics could not be analyzed. However, a distinction between lymphocytes and granulocytes is essential for routine clinical practice regarding diagnosis and further therapy decision. Thus, a follow-up study to address this issue would certainly be worthwhile. Especially since other research groups have succeeded in this area of study in other medical disciplines. Ji et al. were able to show granulocytes as a predictive marker of helicobacter pylori infection in gastric mucosa \[[@b41-medscimonit-24-4198]\]. Eventually, a better identification could be achieved by reducing the acriflavine dose for each probe. In the literature, particularly in gastroenterology literature, one can find different recommended data for acriflavine staining dose. The range varies between 0.02--0.05%. There is no detailed statement regarding the "best" dose to use. Recently however, the study group of Li et al. explores this question further \[[@b29-medscimonit-24-4198]\] and proposed a dose of 0.02%, similar to what was used in our study. Nevertheless, the optimal dose may vary from tissue to tissue or fluid being analyzed. Therefore, a follow-up study should be initiated with a reduced stock solution dose of 0.01%. With a lower dose, the nuclei and other cell structures might be better distinguished.

Conclusions
===========

Until now, CLE has not been firmly established in pulmonology. Indeed, encouraging data in this field are increasing. In this study, we showed that BALF components (alveolar macrophages and leucocytes) are differentiable by CLE-based analysis, offering a new diagnostic approach.
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![Comparison CLE and cytology. (**A1**) Probe-based confocal laser endomicroscopy with proof of alveolar macrophages and increased leucocytes. (**A2**) Cytological analysis, detection of increased neutrophils corresponding to inflammation. (**B1**) CLE aided detection of predominantly leucocytes. (**B2**) Cytological confirmation of mainly lymphocytes with big cell nuclei, in this case infiltration of high grade lymphoma. (**C1**) CLE: mainly alveolar macrophages, normal result. (**C2**) Cytology: mainly alveolar marcophages and monocytes, normal BALF.](medscimonit-24-4198-g001){#f1-medscimonit-24-4198}

###### 

Patients characteristics.

  Patient No   Age years   Sex   Smoking            Histology/cytology      Underlying disease      Detection[\*](#tfn2-medscimonit-24-4198){ref-type="table-fn"}
  ------------ ----------- ----- ------------------ ----------------------- ----------------------- ---------------------------------------------------------------
  1            59          M     Ex, 40PY           Lymphoma infiltration   Lymphoma                Mainly leucocytes
  2            70          M     Ex, 40PY           Regular                 Suspected pneumonia     Regular
  3            70          M     Ex, 40PY           Regular                 Suspected pneumonia     Regular
  4            25          M     Yes, 2--3 cig./d   Regular                 Suspected tbc           Regular
  5            66          F     Ex, 30PY           Inflammatory, regular   NSCLC                   Regular
  6            56          M     Yes                30% lymph               HIV                     Increased leucocytes
  7            50          M     Ex for 7y          Regular                 Sarcoidosis             Regular
  8            51          F     Yes                Regular                 SCLC                    Regular
  9            46          M     No                 Inflammatory            Lung adenocarcinoma     Increased leucocytes
  10           49          M     Yes, 20 cig./d     Regular                 Mycosis fungoides       Regular
  11           28          M     No                 Regular                 Suspected tbc           Regular
  12           82          F     No                 Inflammatory            Suspected eaa           Increased leucocytes
  13           47          F     Yes, 15PY          Inflammatory, regular   COPD                    Regular
  14           21          M     Yes                Regular                 Osteosarcoma            Regular
  15           50          M     Yes                Regular                 Parotid cancer          Regular
  16           67          M     No                 Inflammatory            IgG 4 related disease   Increased leucocytes
  17           33          F     Ex, 5PY            Inflammatory            ALL                     Increased leucocytes
  18           67          M     Yes, 50PY          Regular                 COPD                    Regular
  19           78          F     No                 Inflammatory            Lung adenocarcinoma     Increased leucocytes
  20           63          M     Yes                20% lymph               Dyspnea                 Regular, incr. leuco.
  21           31          M     No                 50%lymph                Sarcoidosis             Regular

Regular=84--99% alveolar macrophages, \<1% epithelial cells, \<4% neutrophils, \<1% eosinophils, \<16% lymphocytes;

reactive/inflammatory=increased neutrophils.
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